Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
Urbain JL, Scott AM, Lee ST, Buscombe J, Weston C, Hatazawa J, Kinuya S, Singh B, Haidar M, Ross A, Lamoureux F, Kunikowska J, Wadsak W, Dierckx R, Paez D, Giammarile F, Lee KH, O JH, Moshe M, Louw L, More S, Nadel H, Lee D, Wahl R. Urbain JL, et al. Among authors: giammarile f. J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4. J Nucl Med. 2023. PMID: 37142302 Free article. No abstract available.
The QuADRANT study: Current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe. The radiotherapy perspective.
Jornet N, Strojan P, Howlett DC, Brady AP, Hierath M, Clark J, Wadsak W, Giammarile F, Coffey M. Jornet N, et al. Among authors: giammarile f. Radiother Oncol. 2023 Sep;186:109772. doi: 10.1016/j.radonc.2023.109772. Epub 2023 Jun 28. Radiother Oncol. 2023. PMID: 37385381 Review.
Six country vignettes: Strengthening radiotherapy and theranostics.
Mikhail-Lette M, Cordero L, Lievens Y, Al-Ibraheem A, Urbain JL, Chera B, Muylle K, Vaandering A, Rosa AA, Cerci JJ, Sathekge M, Minjgee M, Nansalmaa E, Erdenechimeg S, Ruiz RL, Scott A, Paez D, Giammarile F, Veduta A, Minoshima E, Vichare S, Abdel-Wahab M. Mikhail-Lette M, et al. Among authors: giammarile f. J Cancer Policy. 2024 Jun;40:100471. doi: 10.1016/j.jcpo.2024.100471. Epub 2024 Mar 29. J Cancer Policy. 2024. PMID: 38556128
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics.
Scott AM, Zeglis BM, Lapi SE, Scott PJH, Windhorst AD, Abdel-Wahab M, Giammarile F, Piaez D, Jalilian A, Knoll P, Korde A, Vichare S, Ayati N, Lee ST, Lyashchenko SK, Zhang J, Urbain JL, Lewis JS. Scott AM, et al. Among authors: giammarile f. Lancet Oncol. 2024 Jun;25(6):e250-e259. doi: 10.1016/S1470-2045(24)00037-8. Lancet Oncol. 2024. PMID: 38821099 Review.
Production and regulatory issues for theranostics.
Giammarile F, Paez D, Zimmermann R, Cutler CS, Jalilian A, Korde A, Knoll P, Ayati N, Lewis JS, Lapi SE, Delgado Bolton RC, Kunikowska J, Estrada Lobato E, Urbain JL, Holmberg O, Abdel-Wahab M, Scott AM. Giammarile F, et al. Lancet Oncol. 2024 Jun;25(6):e260-e269. doi: 10.1016/S1470-2045(24)00041-X. Lancet Oncol. 2024. PMID: 38821100 Review.
239 results